Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
70.58
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomarin Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
June 27, 2024
Via
Benzinga
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
June 11, 2024
While growth is established for BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), the stock's valuation remains reasonable.
Via
Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
June 07, 2024
KKR and GoDaddy also will join before the open on June 24.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.
Via
InvestorPlace
Looking Into Biomarin Pharmaceutical's Recent Short Interest
May 28, 2024
Via
Benzinga
NASDAQ:BMRN is not too expensive for the growth it is showing.
May 21, 2024
Looking for growth without the hefty price tag? Consider BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN).
Via
Chartmill
Analyst Ratings For Biomarin Pharmaceutical
May 14, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results
June 04, 2024
BridgeBio stock rallies on upbeat study results of a drug for a genetic disease that affects the limbs and spine.
Via
Investor's Business Daily
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
May 19, 2024
Last week, these 10 large-cap stocks had the worst performance. NICE, PBR, FIX, LI, MLM, VMC, BMRN, EDU, GFI, MUFG all saw significant decreases.
Via
Benzinga
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
May 18, 2024
Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
May 09, 2024
Via
Benzinga
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
April 25, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
April 03, 2024
Via
Benzinga
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
May 17, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
May 09, 2024
If you have the appetite for the risk inherent in the biotech sector, here are three biotech stocks to buy in May.
Via
InvestorPlace
Citi Just Cut Its Price Target on These 3 Stocks
May 03, 2024
Reviewing analyst downgrades may help safeguard investment portfolios amid market uncertainty and Citi price target cuts.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
April 30, 2024
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
Via
Chartmill
The Latest Analyst Ratings For Biomarin Pharmaceutical
February 23, 2024
Via
Benzinga
Recap: Biomarin Pharmaceutical Q4 Earnings
February 22, 2024
Via
Benzinga
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
April 27, 2024
Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
April 25, 2024
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.
Via
InvestorPlace
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
April 24, 2024
BMRN stock results show that Biomarin Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
Don't overlook NASDAQ:BMRN—a stock with solid growth prospects and a reasonable valuation.
April 08, 2024
Investors seeking growth at a reasonable cost should explore BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN).
Via
Chartmill
While growth is established for NASDAQ:BMRN, the stock's valuation remains reasonable.
March 18, 2024
Despite its growth, BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) remains within the realm of affordability.
Via
Chartmill
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
March 16, 2024
Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN.
February 26, 2024
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.